Drugs / GSK256066
Trials 10
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00515268 | Sep 2007 → Apr 2008 | chronic obstructive pulmonary disease | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 29 trials · 1 met primary | ||||||
| Phase 2 | NCT00612118 | Feb → May 2008 | seasonal allergic rhinitis | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00612820 | Jan → May 2008 | seasonal allergic rhinitis | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00549744 | Nov 2007 → Aug 2008 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00549679 | Oct 2007 → Dec 2008 | chronic obstructive pulmonary disease | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00464568 | Mar → May 2007 | seasonal allergic rhinitis | GlaxoSmithKline | Completed | Mixed |
| Phase 2 | NCT00430157 | Jan 2007 → ? | seasonal allergic rhinitis | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00380354 | Sep 2006 → Jun 2007 | asthma | GlaxoSmithKline | Completed | Met primary |
| Phase 2 | NCT00445510 | Jun 2006 → ? | asthma | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00377728 | Mar → May 2006 | seasonal allergic rhinitis | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK256066 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00612820 ↗ |
| Action | Inhibit | “phosphodiesterase-4 (PDE4) inhibitor” NCT00377728 ↗ |
| Modality | Small molecule | — CHEMBL570015 ↗ |
| Route | Intranasal | “repeat doses of intranasal GSK256066” NCT00377728 ↗ |